New AI tool accurately portrays metabolic states
RENAISSANCE can quantify unknown intracellular metabolic states, including metabolic fluxes.
List view / Grid view
RENAISSANCE can quantify unknown intracellular metabolic states, including metabolic fluxes.
The nucleic acid drug, iSN04, could have applications for pathological angiogenesis involved in atherosclerosis, cancer, and retinopathy.
The humanised antibody, Hv1Lt1, showed promising results in pancreatic cancer mouse models.
This study is first to demonstrate with statistical certainty that human visceral adipose tissue accumulated in the abdominal cavity secretes more extracellular vesicles.
Targeting the epigenetic states of specific retroelements in the human genome could mitigate the biological effects of ageing.
A new class of RNAs packed into extracellular vesicles have potential as biomarkers for prostate cancer and other diseases.
Researchers have developed a new AI tool which recognises that protein behaviour can vary by cell and by tissue type.
Researchers suggest that integrating genetically diverse mouse models with cell-based assays will better replicate human diseases.
The study highlights the possible therapeutic significance of targeting the pathway for treating obesity and metabolic disease.
Understanding the signalling pathway controlling neural stem cell reactivation could offer a strategy for using existing drugs to treat neurodevelopmental disorders.
Orlando Health Orlando Regional Medical Center is the first hospital in the world to use the blood test.
The discovery that eFT508 blocks eIF4E and the ketogenic pathway could provide the foundation for personalised therapies.
Five distinct CRC prognostic subtypes were identified, which could revolutionise the way CRC is diagnosed and treated.
Researchers showed that internal stress, induced by active cell behaviours, shapes the Drosophila wing disc pouch during eversion.
Genome and transcriptome sequencing revealed that subtypes such as TCF3/4::HLF were associated with an increased risk of relapse.